Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health ELV -2.57% + Free Alerts has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average annual return of 13.22%. Currently, Elevance Health has ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

We came across a bullish thesis on Elevance Health, Inc. (NYSE:ELV) on ValueInvestorsClub by rhubarb. In this article, we ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Elevance Health, Inc. (ELV), with a market cap of $89.92 billion, is a leading health benefits company in the United States.

Rising Dividend Fund A Shares (without sales charge*) posted a return of -5.60% in fourth quarter 2024. Read more here.

Elevance Health’s EVP Kendrick Charles Morgan JR sold shares worth $3.21 million but later repurchased the same amount. This ...